# PRE-STAGE-2 CONSOLIDATION — Project Status Summary

**Generated:** 2026-09-01  
**Status:** READY FOR STAGE 2  

This document summarizes the complete state of the project after Stages 1 and 1.5, and confirms all prerequisites for Stage 2 structural analysis.

---

## EXECUTIVE SUMMARY

### Dataset Composition

| Cohort | Rows | Use | Notes |
|--------|------|-----|-------|
| **SD-H (single-domain antibody)** | 1597 | Primary mechanistic analysis | Camelid VHHs + human sdVH + synthetic + engineered |
| **FAB (paired conventional antibody)** | 2798 | Empirical VH–VL interface reference | All conventional chain-sharing construct |
| **FV (paired conventional antibody)** | 536 | Paired reference (subset) | 294 conventional; 242 engineered chain-sharing excluded |
| **Total Metadata Rows** | **4931** | | |

### Primary Cohorts — Final Eligibility

| Cohort | Rows | Unique SABDAB_ID | Use |
|--------|------|------------------|-----|
| **Strict Natural VHH** | **1328** | 1054 | Primary mechanistic analysis (Stage 2+) |
| Mixed-Provenance VHH | 108 | 5 IDs | Structural QC + sensitivity analysis only |
| Engineered/Humanized Secondary | 3 | | Secondary / control cohort (optional) |
| Manual Review / Uncertain | 19 | | Requires expert assessment |
| **Primary Paired Conventional** | **3092** | — | FAB (2798) + FV conventional (294) for interface reference |
| | | | |
| **Structural-QC VHH Pool** | **1458** | | Strict + mixed + engineered + uncertain |

### Critical Findings from Stage-1 and 1.5

**A. Mixed-Provenance SABDAB_IDs (5 IDs, 108 rows)**

Five variable-domain sequence identities carry conflicting provenance metadata (e.g., some instances labeled Lama glama, others Homo sapiens), yet actual IMGT-numbered sequences are **identical at all shared positions** (zero mismatches). These IDs are **downgraded from primary** but not excluded:

| SABDAB_ID | Instances | Previously Natural | Status |
|-----------|-----------|-------------------|--------|
| H00QEL0000 | 10 | 7 | MIXED_PROVENANCE_SAME_SEQUENCE |
| H021EL0000 | 12 | 9 | MIXED_PROVENANCE_SAME_SEQUENCE |
| H02DAL0000 | 2 | 1 | MIXED_PROVENANCE_SAME_SEQUENCE |
| H02Y5L0000 | 11 | 7 | MIXED_PROVENANCE_SAME_SEQUENCE |
| H06BKL0000 | 2 | 2 | POSSIBLE_DATABASE_INCONSISTENCY (heavy_species text vs heavy_taxid within single row) |

**Implication:** Do not treat these sequences as independent in later deduplication. Sequence identity ≠ provenance identity; these remain structurally valid but provenance-ambiguous.

**B. False Contamination Retraction**

Stage-1 audit incorrectly flagged 58 rows of `sabdab2_H02Y5L0000` as non-antibody MHC contamination (compound text: "Single chain trimer HLA-A\*02:01..."). Stage-1.5 chain-level verification confirmed:

- The SAbDab2 Hchain is a **genuine ~112–117 aa VHH domain** (canonical FR1/FR2/CDR3/FR4, no linkers, no MHC sequence)
- The MHC/HLA/beta-2-microglobulin material is a **separate antigen entity** (chain A in the same PDB)
- **Zero confirmed non-antibody contamination** among those 58 rows

This is a documented false positive (not an error to hide); the audit trail is preserved.

**C. Mutated Natural-Camelid VHHs**

88 rows in the strict primary cohort carry `mutation_flag` (point mutations, affinity maturation, experimental variants). These are **not excluded**; mutation status is tracked separately (`natural_camelid_mutated_flag`) for future sensitivity analysis:

- Strict primary including mutants: 1328 rows
- Strict primary excluding mutants: 1240 rows
- Later analyses may use either set depending on biological question

**D. SABDAB_ID Semantics**

Empirical finding: all five investigated mixed-provenance SABDAB_IDs show zero amino-acid mismatches at shared IMGT positions. Therefore:

- **SABDAB_ID remains valid as sequence-redundancy grouping key for deduplication**
- **SABDAB_ID is NOT a provenance/biological-origin identifier**
- Sequence identity and provenance are independent concepts

---

## STAGE-1 METADATA OVERVIEW

### SD-H Classification (Original)

| Category | Rows | Notes |
|----------|------|-------|
| Natural camelid candidate | 1419 | Primary: Camelus, Lama, Vicugna taxa |
| Human sdVH candidate | 91 | Excluded: Homo sapiens origin |
| Synthetic or de-novo | 61 | Excluded: artificial construct |
| Engineered or humanized camelid | 3 | Secondary: camelid origin + explicit engineering |
| Uncertain sdH | 21 | Manual review: ambiguous evidence |
| Other non-camelid sdH | 2 | Excluded: non-camelid non-human |
| **Total SD-H** | **1597** | |

### Stage-1.5 Derived Eligibility (Conservative Policy)

After mixed-provenance downgrade and priority rule application:

| Derived Status | Rows | Criteria | Downstream Use |
|----------------|------|----------|-----------------|
| RESOLVED_NATURAL_CAMELID | 1328 | Natural camelid + not mixed-provenance | Primary mechanistic analysis |
| MIXED_PROVENANCE_SAME_SEQUENCE | 108 | Any of 5 mixed-provenance IDs | Structural QC, sensitivity only |
| RESOLVED_ENGINEERED_OR_HUMANIZED | 3 | Explicit humanization/engineering | Secondary / control |
| MANUAL_REVIEW | 19 | Uncertain_sdH not in mixed-provenance | Expert review required |
| EXCLUDED (human, synthetic, other) | 139 | Original exclusion criteria | Off primary path |

### Paired-Antibody Cohorts

| Cohort | Rows | Comment |
|--------|------|---------|
| FAB (all conventional) | 2798 | All chain types are conventional paired H+L |
| FV conventional | 294 | Conventional paired; rest (242 rows) are chain-sharing engineered constructs |
| FV SCFV | 223 | Single-chain variable: excluded from paired-reference analysis |
| FV DIABODY / other | 19 | Other engineered: excluded |

---

## STAGE-1 VISUALIZATION SUITE

**Status:** ✓ COMPLETE AND VALIDATED

### Generated Figures (8 required + 0 supplementary so far)

| Figure ID | Title | Format | Size | Validation |
|-----------|-------|--------|------|-----------|
| FIG_S1_01 | Dataset and Curation Flow | PNG + SVG | 4166×1814 | ✓ PASS |
| FIG_S1_02 | SD-H Classification Distribution | PNG + SVG | 2970×1769 | ✓ PASS |
| FIG_S1_03 | Primary VHH Species Distribution | PNG + SVG | 2970×1770 | ✓ PASS |
| FIG_S1_04 | FV Construct Architecture | PNG + SVG | 2969×1770 | ✓ PASS |
| FIG_S1_05 | Final VHH Provenance Tiers | PNG + SVG | 2969×1788 | ✓ PASS |
| FIG_S1_06 | Redundancy and Pseudoreplication (QC) | PNG + SVG | 3269×1770 | ✓ PASS |
| FIG_S1_07 | Metadata Quality Assessment (QC) | PNG + SVG | 3569×2955 | ✓ PASS |
| FIG_S1_08 | Mixed-Provenance Audit | PNG + SVG | 4768×1191 | ✓ PASS |

**Location:** `results/figures/stage1/`  
**Manifest:** `results/figures/stage1/figure_manifest.csv`  
**Documentation:** `results/figures/stage1/README.md`

### Color Palette

All figures use **Gordon-inspired semantic colors** (project-standard):

- VHH / sdAb: **#4D69B2** (blue)
- Conventional antibody: **#EF7F7E** (pink)
- Conventional VH: **#8670B1** (purple)
- Excluded / grey: **#CCCCCC**

Defined in: `configs/visualization.yaml`  
Documented in: `docs/visualization_standard.md`

---

## CRITICAL PROJECT OUTPUTS

### Master Metadata Table

**Original (unchanged):**
- `data/metadata/master_stage1.parquet` (4931 rows × 96 columns)
- `data/metadata/master_stage1.csv`

**Derived (new eligibility layer, no original fields modified):**
- `data/metadata/master_stage1_resolved.parquet` (4931 rows × 102 columns)
- `data/metadata/master_stage1_resolved.csv`

**6 new derived fields** (Stage-1.5):
- `primary_vhh_candidate_strict` (bool)
- `vhh_candidate_structural_qc` (bool)
- `vhh_candidate_sensitivity` (bool)
- `sequence_provenance_ambiguity` (bool)
- `provenance_resolution_status` (enum)
- `natural_camelid_mutated_flag` (bool)

### Audit Documentation

| File | Purpose | Location |
|------|---------|----------|
| Stage-1 Boundary-Case Audit | Identified mixed-provenance and uncertain rows | `results/audits/stage1_classification_boundary_audit.md` |
| Stage-1.5 Targeted Verification | Chain-level proof of no contamination | `results/audits/stage1_5_targeted_verification.md` |
| Stage-1.5 Resolution Policy | Conservative downgrade policy applied | `results/audits/stage1_5_resolution_policy.md` |

### Configuration

| File | Purpose |
|------|---------|
| `configs/visualization.yaml` | Semantic color palette + figure standards (machine-readable) |
| `docs/visualization_standard.md` | Visualization philosophy + figure design guide (human-readable) |

---

## STAGE 2 READINESS CHECKLIST

- [x] All 4931 metadata rows loaded and classified
- [x] Provenance conflicts documented and handled conservatively
- [x] False contamination claim retracted and verified
- [x] Primary cohorts defined (1328 strict natural VHH + 3092 conventional paired)
- [x] Secondary/control cohorts identified (mixed-provenance, engineered, uncertain)
- [x] Duplicate archive resolved (FAB content_duplicate_flag set)
- [x] APFS case-collision handled (all 22 conflicting files renamed and mapped)
- [x] Raw mmCIF extraction manifest complete (6323 archive members mapped)
- [x] 8 Stage-1 figures generated, validated, and documented
- [x] Project visualization standard defined and applied
- [x] All Stage-1 outputs reproducible via documented scripts
- [x] Pytest suite passes (18 tests, all green)
- [x] No raw data modified
- [x] No coordinate-level analysis performed
- [x] No MD software installed
- [x] No Stage-2 structural QC started

---

## STAGE 2 ENTRY REQUIREMENTS

Stage 2 will perform structure-level QC, interface derivation, and mechanistic analysis:

### Stage-2 Scope: Structure-Level QC and Cohort Validation

**ONLY the following are performed in Stage 2:**

1. **Hchain and Lchain Entity Mapping:**
   - PDB entity identification (which chain is the antibody Hchain?)
   - IMGT-numbered variable-domain coordinates
   - Lchain presence/absence verification (expected: absent for SD-H, present for paired)

2. **Variable-Domain Completeness:**
   - Residue coverage from IMGT position 1 to 128 (Kabat 104)
   - Percentage of each CDR observed in coordinates
   - Backbone trace continuity checks
   - Exclusion/failure reasons documented

3. **Paired Antibody Validation:**
   - VH–VL separation and contact verification
   - Both chains structured for conventional paired cohort

4. **Protein-Antigen Entity Identification:**
   - Which non-antibody chain(s) represent the antigen?
   - Gordon-compatible protein-antigen inclusion: Cα distance ≤4.5 Å to any VHH/VH residue?

5. **Cohort Reduction Accounting:**
   - How many structures fail coordinate-level QC?
   - Exclusion reasons enumerated (missing CDR1, no Lchain when expected, etc.)
   - Final structural cohort size: how many rows survive Stage 2?

### Stage-2 Output

- Updated metadata table with coordinate-QC flags
- Validated structural cohort (reduced from 1458 → final count)
- 1–3 representative 3D examples (if scientifically valuable: one validated VHH–antigen, one validated paired VH–VL–antigen)
- Cohort-reduction summary (if materially significant, 1 funnel figure)

### **NOT in Stage 2** (deferred to Stage 3+):

- CDR3 geometry calculation (Gordon R3 reach, theta, phi, compactness)
- CDR3 shielding quantification (delta-SASA counterfactual)
- Empirical VH–VL interface derivation (ΔSASA analysis, interface position mapping)
- Hydrophobic-surface exposure analysis
- Arpeggio mechanistic interactions
- APBS electrostatics
- AggreScan3D aggregation proxies
- Statistical mechanistic modeling

These belong to Stage 3+ mechanistic analysis after the structural cohort is validated.

### Stage-2 Data Inputs

- Extracted mmCIF files in `data/raw_extracted/`
- Master metadata in `data/metadata/master_stage1_resolved.parquet`
- Visualization standards in `configs/visualization.yaml` (apply scientific gate)
- Example paired structures for validation reference (no interface derivation)

### Stage-2 Visualization (per scientific gate)

- Representative 3D structures ONLY if antigen-binding geometry interpretation is useful (justified: yes)
- Cohort-reduction funnel ONLY if structure-level QC substantially reduces dataset (justified: maybe)
- No other plots; tables sufficient for coordinate-QC results

---

## KNOWN LIMITATIONS AND CAVEATS

1. **Mixed-Provenance Uncertainty:** Five IDs with identical sequences but conflicting provenance labels; resolution recommended before publication.
2. **H06BKL0000 Self-Contradiction:** One row (pdb_00009q00) has heavy_species="Vicugna pacos" but heavy_taxid=9606 (human); likely data error at SAbDab2 source.
3. **Uncertain Rows:** 19 rows remain unclassified (original 21 minus 2 in mixed-provenance set); no automated decision applied.
4. **Mutation-Flagged VHHs:** 88 primary candidates carry point mutations; future work must decide whether to include in strict mechanistic comparison.
5. **No Sequence-Level Validation:** This project uses SAbDab2 taxonomy directly; alternative sequencing/protein-identification methods not cross-checked.
6. **Antigen Assignment TBD:** Current data identifies protein-antigen rows but does not extract chain/residue mappings; Stage 2 will require per-structure inspection.

---

## NEXT STEPS

**To start Stage 2:**

1. Review mixed-provenance findings and decide provenance resolution strategy
2. Extract and validate mmCIF coordinates for all primary candidates
3. Implement variable-domain completeness and QC filtering
4. Derive empirical VH–VL interface from conventional paired structures
5. Calculate ΔSASA shielding metrics for VHH candidates
6. Quantify CDR3 geometry and correlate with shielding

---

## QUICK REFERENCES

- **Project root:** `/Users/betulgul/Desktop/staj`
- **Primary metadata:** `data/metadata/master_stage1_resolved.parquet`
- **Figures directory:** `results/figures/stage1/`
- **Configuration:** `configs/visualization.yaml`
- **Source scripts:** `src/qc/stage1_*.py` + `src/visualization/stage1_figures.py`
- **Visualization docs:** `docs/visualization_standard.md`

---

**PRE-STAGE-2 CONSOLIDATION STATUS: PASS**

**STAGE 1 VISUALIZATION STATUS: PASS**

**Ready to proceed to Stage 2 structural analysis.**
